The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
Zydus receives EIR for the API manufacturing facility at Ankleshwar
The Subsidiary has received one inspectional observation in Form 483
This unit will focus on the manufacturing of health and wellness equipment
The plant will have installed production capacity of 3,120 MT/month
The products will be manufactured in Goa India and marketed & distributed in Australian markets
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
the inspection conducted from January 27 to January 31, 2025
The facility is equipped with state-of-the-art technology to produce high-quality lyophilized (freeze-dried) products
Subscribe To Our Newsletter & Stay Updated
